These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36389185)

  • 21. Circulating microRNAs in patients with active pulmonary tuberculosis.
    Fu Y; Yi Z; Wu X; Li J; Xu F
    J Clin Microbiol; 2011 Dec; 49(12):4246-51. PubMed ID: 21998423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis.
    Liang Q; Jin W; Huang Z; Yin H; Liu S; Liu L; Song X; Wang Z; Fei J
    Front Cell Infect Microbiol; 2023; 13():1125946. PubMed ID: 36926516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining interferon-
    Lv D; Liu Y; Guo F; Wu A; Mo Y; Wang S; Chu J
    J Int Med Res; 2020 Jun; 48(6):300060520925660. PubMed ID: 32527178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection.
    Kang YJ; Park H; Park SB; Kim J; Lee J; Kim J; Park S; Lee YS; Kim S
    J Clin Tuberc Other Mycobact Dis; 2021 Aug; 24():100253. PubMed ID: 34278005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis.
    Mamishi S; Mahmoudi S; Banar M; Hosseinpour Sadeghi R; Marjani M; Pourakbari B
    Mol Biol Rep; 2019 Dec; 46(6):6263-6269. PubMed ID: 31564016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube.
    Nemes E; Abrahams D; Scriba TJ; Ratangee F; Keyser A; Makhethe L; Erasmus M; Mabwe S; Bilek N; Rozot V; Geldenhuys H; Hatherill M; Lempicki MD; Holm LL; Bogardus L; Ginsberg AM; Blauenfeldt T; Smith B; Ellis RD; Loxton AG; Walzl G; Andersen P; Ruhwald M
    Clin Infect Dis; 2019 Oct; 69(10):1724-1730. PubMed ID: 30668657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection.
    Yang BF; Zhai F; Yu S; An HJ; Cao ZH; Liu YH; Wang R; Cheng XX
    Curr Med Sci; 2022 Dec; 42(6):1201-1212. PubMed ID: 36462134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High miRNA-378 expression has high diagnostic values for pulmonary tuberculosis and predicts adverse outcomes.
    Sun X; Liu K; Zhao Y; Zhang T
    BMC Mol Cell Biol; 2022 Mar; 23(1):14. PubMed ID: 35305574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deregulated microRNAs in CD4+ T cells from individuals with latent tuberculosis versus active tuberculosis.
    Fu Y; Yi Z; Li J; Li R
    J Cell Mol Med; 2014 Mar; 18(3):503-13. PubMed ID: 24373112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of unique key genes and miRNAs in latent tuberculosis infection by network analysis.
    Lin Y; Zhang Y; Yu H; Tian R; Wang G; Li F
    Mol Immunol; 2019 Aug; 112():103-114. PubMed ID: 31082644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of an interferon-gamma release assay as a potential diagnostic aid for active pulmonary tuberculosis.
    Taki-Eddin L; Monem F
    J Infect Dev Ctries; 2012 Jan; 6(1):67-72. PubMed ID: 22240431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection.
    Balcells ME; Ruiz-Tagle C; Tiznado C; García P; Naves R
    Tuberculosis (Edinb); 2018 Sep; 112():110-119. PubMed ID: 30205963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying miRNAs Associated with the Progression of Keloid through mRNA-miRNA Network Analysis and Validating the Targets of miR-29a-3p in Keloid Fibroblasts.
    He Y; Zhang Z; Yin B; Li S; Wang P; Lan J; Lian W; Jia C
    Biomed Res Int; 2022; 2022():6487989. PubMed ID: 35872873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The meta-analysis for ideal cytokines to distinguish the latent and active TB infection.
    Wei Z; Li Y; Wei C; Li Y; Xu H; Wu Y; Jia Y; Guo R; Jia J; Qi X; Li Z; Gao X
    BMC Pulm Med; 2020 Sep; 20(1):248. PubMed ID: 32948170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
    Suzukawa M; Akashi S; Nagai H; Nagase H; Nakamura H; Matsui H; Hebisawa A; Ohta K
    PLoS One; 2016; 11(4):e0152483. PubMed ID: 27035669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
    de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels of microRNA miR-16 and miR-155 are altered in serum of patients with tuberculosis and associate with responses to therapy.
    Wagh V; Urhekar A; Modi D
    Tuberculosis (Edinb); 2017 Jan; 102():24-30. PubMed ID: 28061948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of miRNA and cytokine expressions in latent tuberculosis infection and active tuberculosis.
    Çavuşoğlu C; Çoğulu Ö; Durmaz A; Cengisiz Z; Yılmaz FF; Taşbakan MS; Taşbakan M; Gündüz C; Biçmen C; Karaman O; Taşlıdere H; Akın H; Akarca T; Dereli Ş
    Turk J Med Sci; 2022 Jun; 52(3):649-657. PubMed ID: 36326316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children.
    Connell TG; Curtis N; Ranganathan SC; Buttery JP
    Thorax; 2006 Jul; 61(7):616-20. PubMed ID: 16601088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.